US And Canada

The low Earth orbit mapping technology provider has raised more than $100m altogether, having picked up series A financing from Weru Investment in 2018.

Stablix Therapeutics has launched with $63m in equity financing to commercialise research pioneered in Henry Colecraft’s laboratory at Columbia University.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Stanford has contributed to a $26m series A for Jeeves, which was announced concurrently with a $5m seed round and $100m in debt financing.

The oncology therapy developer has filed for an IPO just two years after emerging from stealth to advance Harvard and Stanford research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.

As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.

Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.

VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.